Parr N - Search Results

1

Feasibility study of a randomised controlled trial to compare (deferred) androgen deprivation therapy and cryotherapy in men with localised radiation-recurrent prostate cancer.

Salji M, Jones R, Paul J, Birrell F, Dixon-Hughes J, Hutchison C, Johansen TE, Greene D, Parr N, Leung HY; Cryotherapy in Prostate Cancer (CROP) study team. Salji M, et al. Among authors: parr n. Br J Cancer. 2014 Jul 29;111(3):424-9. doi: 10.1038/bjc.2014.316. Epub 2014 Jun 19. Br J Cancer. 2014. PMID: 24946001 Free PMC article.

2

Referrals into a dedicated British penile cancer centre and sources of possible delay.

Lucky MA, Rogers B, Parr NJ. Lucky MA, et al. Among authors: parr nj. Sex Transm Infect. 2009 Dec;85(7):527-30. doi: 10.1136/sti.2009.036061. Epub 2009 Jul 6. Sex Transm Infect. 2009. PMID: 19584061

3

The treatment of penile carcinoma in situ (CIS) within a UK supra-regional network.

Lucky M, Murthy KV, Rogers B, Jones S, Lau MW, Sangar VK, Parr NJ. Lucky M, et al. BJU Int. 2015 Apr;115(4):595-8. doi: 10.1111/bju.12878. Epub 2014 Dec 15. BJU Int. 2015. PMID: 25060513

4

Lateral spine radiographs before androgen deprivation treatment detect a high incidence of undiagnosed vertebral fragility fractures in men with advanced prostate cancer.

Mistry R, Hughes D, Wadhwa V, Parr N. Mistry R, et al. Among authors: parr n. J Urol. 2011 Aug;186(2):474-80. doi: 10.1016/j.juro.2011.03.149. Epub 2011 Jun 25. J Urol. 2011. PMID: 21705031

5

Peripheral or axial bone density measurements to identify osteoporosis in prostate cancer patients undergoing androgen deprivation therapy?

Wadhwa VK, Parr NJ. Wadhwa VK, et al. Urology. 2009 Jun;73(6):1347-51. doi: 10.1016/j.urology.2009.01.055. Epub 2009 Apr 10. Urology. 2009. PMID: 19362345

6

Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.

Wadhwa VK, Weston R, Mistry R, Parr NJ. Wadhwa VK, et al. BJU Int. 2009 Sep;104(6):800-5. doi: 10.1111/j.1464-410X.2009.08483.x. Epub 2009 Mar 11. BJU Int. 2009. PMID: 19338564

7

Immediate dual energy X-ray absorptiometry reveals a high incidence of osteoporosis in patients with advanced prostate cancer before hormonal manipulation.

Hussain SA, Weston R, Stephenson RN, George E, Parr NJ. Hussain SA, et al. Among authors: parr nj. BJU Int. 2003 Nov;92(7):690-4. doi: 10.1046/j.1464-410x.2003.04471.x. BJU Int. 2003. PMID: 14616447 Clinical Trial.

8

Frequency of zoledronic acid to prevent further bone loss in osteoporotic patients undergoing androgen deprivation therapy for prostate cancer.

Wadhwa VK, Weston R, Parr NJ. Wadhwa VK, et al. BJU Int. 2010 Apr;105(8):1082-8. doi: 10.1111/j.1464-410X.2009.08956.x. Epub 2009 Nov 13. BJU Int. 2010. PMID: 19912210 Clinical Trial.

9

Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer.

Wadhwa VK, Weston R, Parr NJ. Wadhwa VK, et al. BJU Int. 2011 Jun;107(12):1923-9. doi: 10.1111/j.1464-410X.2010.09726.x. Epub 2010 Oct 15. BJU Int. 2011. PMID: 20950306

10

Penile metastases treated with partial glansectomy and adjuvant radiotherapy 5 years after an initial diagnosis of rectal cancer.

McGuinness LA, Floyd MS Jr, Lucky M, Parr NJ. McGuinness LA, et al. Among authors: parr nj. BMJ Case Rep. 2013 Dec 5;2013:bcr2013200829. doi: 10.1136/bcr-2013-200829. BMJ Case Rep. 2013. PMID: 24311411 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

170 results

Search Page